MiNK Therapeutics Presents New Preclinical and Clinical Data on iNKT Cell Therapy Programs at SITC 2021

NEXT STORY
Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and uveal melanoma (mUM) at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
PREV STORY
The Worldwide Biosimilars Industry is Expected to Reach $44.7 Billion by 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New 2-in-1 powder aerosol medicine to stop deadly superbugs in the lungs

A Purdue University drug formulation incorporates two antibiotics to help fight the global crisis ...

author_avatar
NASDAQ Market News

Cesca Therapeutics Inc. Presents New Data on its Proprietary X-Series™ Cellular Processing Systems

Two posters presented at the International Society for Cellular Therapy (ISCT)2018 Annual Meeting RANCHO ...

author_avatar
NASDAQ Market News

Indi Molecular Appoints Stephen Worsley Senior VP Business Development

CULVER CITY, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Indi Molecular, an emerging life ...

author_avatar
NASDAQ Market News